Reflect Scientific, Inc. (RSCF)
OTCMKTS · Delayed Price · Currency is USD
0.0491
-0.0009 (-1.80%)
Nov 3, 2025, 3:55 PM EST
Reflect Scientific Market Cap
Reflect Scientific has a market cap or net worth of $4.49 million as of November 3, 2025. Its market cap has decreased by -4.90% in one year.
Market Cap
4.49M
Enterprise Value
3.66M
Revenue
1.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since July 7, 2005, Reflect Scientific's market cap has decreased from 24.00M to 4.49M, a decrease of -81.30%. That is a compound annual growth rate of -7.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 4.47M | 24.29% |
| Dec 31, 2024 | 3.60M | -36.51% |
| Dec 29, 2023 | 5.67M | 8.77% |
| Dec 30, 2022 | 5.21M | -48.72% |
| Dec 31, 2021 | 10.16M | -76.02% |
| Dec 31, 2020 | 42.37M | 1,206.32% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |